CA
AFJK

Crossingbridge Advisors’s Aimei Health Technology Co AFJK Stock Holding History

Crossingbridge Advisors’s Portfolio AFJK Stock Details AFJK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-193,270
Closed -$2.19M – 106
2025
Q3 		$2.19M Sell
193,270
-22
-0% -$247 1.12% 21
2025
Q2 		$2.15M Buy
+193,292
New +$2.14M 1.88% 15

Other funds holding AFJK

FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.28% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DWM
Dakota Wealth Management Palm Beach Gardens, Florida $5.24B AUM 38.12% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Crossingbridge Advisors's AFJK Position: Q4 2025 in Review

Crossingbridge Advisors sold out of Aimei Health Technology Co (AFJK) in Q4 2025, closing a stake of 193,270 shares — an estimated $2.19M sold.

Crossingbridge Advisors first reported a position in AFJK in Q2 2025 and held it in 2 quarters. The position peaked at $2.19M in Q3 2025. 11 funds tracked by Wall St. Rank hold AFJK as of Q4 2025.

  • Crossingbridge Advisors reported no remaining Aimei Health Technology Co position as of Q4 2025 after selling out during the quarter.
  • Crossingbridge Advisors sold 193,270 Aimei Health Technology Co shares in Q4 2025, an estimated $2.19M.
  • Crossingbridge Advisors first reported a position in Aimei Health Technology Co in Q2 2025 and held it in 2 quarters.
  • Crossingbridge Advisors's Aimei Health Technology Co position peaked at $2.19M in Q3 2025.
  • 11 funds tracked by Wall St. Rank held Aimei Health Technology Co as of Q4 2025.

Based on Crossingbridge Advisors's 13F filing for Q4 2025, filed 13 Feb 2026.